THY1 and neoplasm: Indeed, except for human ovarian cancer and nasopharyngeal carcinoma, where CD90 seems to play a tumor suppressor role [32, 33], several works reported that CD90 overexpression in the tumor microenvironment enhances proliferation and metastasis, conferring the poorest outcome [10, 34–36].